SCHEMBL30161393

SCHEMBL30161393

[C-]#[N+]c1cc(Br)n(CC(C)(C)CC(=O)Cl)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30161775 0.88 ALDH1A1 (0.31)
SCHEMBL24035522 0.76 GAA (0.31)
SCHEMBL24035650 0.69 GAA (0.34)
SCHEMBL24035530 0.63 GAA (0.32)
SCHEMBL24031598 0.63
SCHEMBL24035535 0.60 POLB (0.34)
SCHEMBL11318440 0.60
SCHEMBL665258 0.59 TSHR (0.45)
SCHEMBL24031578 0.57 GAA (0.34)
SCHEMBL2056465 0.56 TSHR (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192703-A1 Polycyclic amide derivative as CDK9 inhibitor, preparation method therefor and use thereof Suzhou Alphama Biotechnology Co., Ltd. (CN) 2023-06-22 US disclosed
EP-4141004-A1 POLYCYCLIC AMIDE DERIVATIVE AS CDK9 INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF Suzhou Alphama Biotechnology Co., Ltd. (CN) 2023-03-01 EP disclosed
CN-113149996-B Polycyclic amide derivative as CDK9 inhibitor, and preparation method and application thereof 苏州阿尔脉生物科技有限公司 2022-12-20 CN disclosed